Farmington, CT: 
Lifetime cannabis use is associated
with lower rates of prostate cancer,
according to observational 
data published in the journal Biomedicines

Researchers affiliated with the University of Connecticut School of Medicine
and the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida
assessed the relationship between cannabis consumption and
prostate cancer in a nationally representative cohort of 2,503 participants. 

Investigators reported that subjects between the ages of 50 and 64
who identified as either current or former cannabis consumers
possessed a significantly lower risk of prostate cancer diagnoses.
Scientists suggested that this finding provides “biological support
for the anti-cancer effects of the constituents of marijuana.
” Numerous preclinical trials have documented 
the ability of cannabinoids to inhibit cancer cell growth. 
To Read the entire article, click here